(Press-News.org) MINNEAPOLIS/ST. PAUL (06/09/2023) — In a new study published in The Lancet Infectious Diseases, University of Minnesota researchers found that metformin, a drug commonly used to treat diabetes, prevents the development of long COVID.
The study, called COVID-OUT, investigated if early outpatient COVID-19 treatment with metformin, ivermectin or fluvoxamine could prevent long COVID. Long COVID is a chronic illness that can affect up to 10% of people who have had COVID-19.
“The results of this study are important because long COVID can have a significant impact on people's lives,” said Carolyn Bramante, MD, principal investigator and an assistant professor at the U of M Medical School. “Metformin is an inexpensive, safe and widely available drug, and its use as a preventive measure could have significant public health implications.”
This was a large, placebo-controlled randomized clinical trial which enrolled volunteers across the United States. The study found:
Those who received metformin were more than 40% less likely to develop long COVID than those who received an identical looking placebo.
For participants who started metformin less than four days after their COVID symptoms started, metformin decreased the risk of long COVID by 63%.
The effect was consistent across different demographic populations of volunteers who participated and across multiple viral variants, including the Omicron variant.
Ivermectin and fluvoxamine did not prevent long COVID.
The study included more than 1,200 participants who were randomly chosen to receive either metformin or placebo, and an additional subset received ivermectin, fluvoxamine or their placebos. Participants were between 30 and 85 years old who qualified as overweight or obese. Over 1,100 of the participants reported on their symptoms for up to 10 months after their initial COVID-19 diagnosis.
“This long-term outcome from a randomized trial is high-quality evidence that metformin prevents harm from the SARS-CoV-2 virus,” said Dr. Bramante, who is also an internist and pediatrician with M Health Fairview. “While half of our trial had been vaccinated, none had been previously infected with the COVID-19 virus. Further research could show whether it is also effective in those with previous infection or in adults with lower body mass index.”
Metformin’s ability to stop the virus was predicted by a simulator developed by U of M Medical School and College of Science and Engineering Biomedical Engineering faculty. The model has been highly accurate to date, successfully predicting, among others, the failure of hydroxychloroquine and the success of remdesivir before the results of clinical trials testing these therapies were announced.
Funding was provided by the Parsemus Foundation, Rainwater Charitable Foundation, Fast Grants and the United Health Foundation.This research was also supported by the National Institutes of Health’s National Center for Advancing Translational Sciences under award number [UL1TR002494, KL2TR002492, and UM1TR004406].
-30-
The University of Minnesota Medical School, School of Public Health, College of Science and Engineering and M Health Fairview served as the lead site. The trial was also conducted at Northwestern University; University of Colorado, Denver; Olive View – UCLA Education & Research Institute in Los Angeles; Optum Health, and with scientific collaboration from partners at the University of North Carolina at Chapel Hill, Vanderbilt University, and Emory University School of Medicine.
The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health’s National Center for Advancing Translational Sciences.
About the University of Minnesota Medical School
The University of Minnesota Medical School is at the forefront of learning and discovery, transforming medical care and educating the next generation of physicians. Our graduates and faculty produce high-impact biomedical research and advance the practice of medicine. We acknowledge that the U of M Medical School, both the Twin Cities campus and Duluth campus, is located on traditional, ancestral and contemporary lands of the Dakota and the Ojibwe, and scores of other Indigenous people, and we affirm our commitment to tribal communities and their sovereignty as we seek to improve and strengthen our relations with tribal nations. For more information about the U of M Medical School, please visit med.umn.edu.
END
Study shows metformin lowers the risk of getting long COVID
2023-06-09
ELSE PRESS RELEASES FROM THIS DATE:
University of Minnesota theoretical physicists help expand the search for new particle
2023-06-09
One of the most high-profile mysteries in physics today is what scientists refer to as the “Strong CP Problem.” Stemming from the puzzling phenomenon that neutrons do not interact with electric fields despite being made up of quarks—smaller, fundamental particles that carry electric charges—the Strong CP Problem puts into question the Standard Model of physics, or the set of theories scientists have been using to explain the laws of nature for years.
A team led by University of Minnesota Twin Cities theoretical physicists has discovered a new way to search for axions, hypothetical particles that could help solve this mystery. Working ...
Novel gene therapy proving safe and successful in sickle cell patients treated at Cleveland Clinic Children’s
2023-06-09
Cleveland: Researchers presenting preliminary data from a clinical trial aimed at discovering a cure for sickle cell disease reveal positive results among its first patients.
Sickle cell disease, a genetic blood disorder, is a painful and debilitating condition for which there are few approved therapies.
Researchers involved in the multicenter Ruby Trial presented an update on the safety and effectiveness of a single dose of EDIT-301, an experimental one-time gene editing cell therapy that modifies a patient’s own blood-forming stem cells to correct the mutation responsible for sickle ...
Campi Flegrei volcano edges closer to possible eruption
2023-06-09
The Campi Flegrei volcano in southern Italy has become weaker and more prone to rupturing, making an eruption more likely, according to a new study by researchers at UCL (University College London) and Italy’s National Research Institute for Geophysics and Volcanology (INGV).
The volcano, which last erupted in 1538, has been restless for more than 70 years, with two-year spikes of unrest in the 1950s, 1970s and 1980s, and a slower phase of unrest over the last decade. Tens of thousands of small earthquakes have occurred during these periods ...
The first prehistoric wind instruments discovered in the Levant
2023-06-09
Although the prehistoric site of Eynan-Mallaha in northern Israel has been thoroughly examined since 1955, it still holds some surprises for scientists. Seven prehistoric wind instruments known as flutes, recently identified by a Franco-Israeli team1, are the subject of an article published on 9 June in Nature Scientific Reports. The discovery of these 12,000 -year-old aerophones is extremely rare – in fact, they are the first to be discovered in the Near East. The “flutes”, made from the bones of a small waterfowl, produce a sound similar to certain birds of prey (Eurasian sparrowhawk and common kestrel) when air is blown ...
Study highlights why people who are sexually harassed might not come forward immediately, or at all
2023-06-09
New research has revealed there is a gap between how people imagine they’d act if sexually harassed and how those who experience it respond.
The study by the University of Exeter, funded by the Economic and Social Research Council and published in Psychology of Women Quarterly, discovered that seeking justice by coming forward is just one of the needs people who experience sexual harassment consider after the event, with other needs, including those for safety, instead rated as more important.
The research may explain why people who ...
New high-tech helmets may protect American football players from debilitating concussions
2023-06-09
Millions of people in the US are concussed every year playing sports. Players of games like American football are at particularly high risk for injuries that can have devastating long-term consequences. Stanford University scientists working with the company Savior Brain have now designed one potential way of protecting players: a helmet containing liquid shock absorbers that could reduce the impact of blows to the head by a third.
“Most of the members of our team have a personal connection to traumatic brain injury and we care deeply about ensuring long-term ...
Genomic resources to help boost climate resilience of fisheries
2023-06-09
Candidate genes that could help fish to tolerate warmer and saltier water have been identified in new research from the Earlham Institute, potentially providing a vital resource to guide breeding programmes in freshwater aquaculture.
As water quality and availability is reduced by higher global temperatures, these insights can be used to breed more resilient fish and safeguard a key source of food for millions of people.
The Nile tilapia, Oreochromis niloticus, is widely farmed in freshwater aquaculture, providing essential nutrients and protein. Their use in aquaculture has risen dramatically, largely due to their adaptability to different water conditions and ...
New method takes the uncertainty out of oxide semiconductor layering
2023-06-09
Tokyo, Japan – 3D integrated circuits are a key part of improving the efficiency of electronics to meet the considerable demands of consumers. They are constantly being developed, but translating theoretical findings into actual devices is not easy. Now, a new design by a research team from Japan can turn these theories into reality.
In a study recently published for the VLSI Symposium 2023, researchers from Institute of Industrial Science, The University of Tokyo have reported a deposition process for nanosheet oxide semiconductor. The oxide semiconductor resulting from this process has high carrier mobility and reliability in transistors.
3D ...
Preparing the stage for 6G: A fast and compact transceiver for Sub-THz frequencies
2023-06-09
New transceiver design capable of both transmission and reception at frequencies over 100 GHz and at 112 Gb/s data rate could pave the way to 6G technologies, as reported by scientists at Tokyo Tech. By effectively suppressing the self-interference caused by the transmission signal leaking into the receiver, the proposed architecture reaches unprecedented data rates while maintaining a surprisingly compact size.
Scientists and engineers in the field of telecommunications are already working on the technologies that will be used for sixth generation (6G) networks. Ideally, 6G should deliver data rates of ...
Researchers to explore potential of new treatment against vascular dementia
2023-06-09
EL PASO, Texas (June 8, 2023) – Researchers from The University of Texas at El Paso’s School of Pharmacy will explore the viability of a new treatment for vascular dementia, thanks to a $2.2 million grant from the National Institutes of Health (NIH) National Institute of Neurological Disorders and Stroke (NINDS). The grant builds on work that’s previously been done by the team and their collaborators.
Vascular dementia — the second most common type of dementia worldwide — ...